Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Clinical Advancements and Modern Approaches in the field of Diabetes
- Diabetes Congress 2018

About Diabetes 2018

Diabetes mellitus is a common, serious health condition that increases the levels of glucose in blood. Most of the glucose attained by the body comes from the food we take. This conference mainly deals with the causes of the diabetes, pathophysiology of diabetes, complications of diabetes, current focuses of diabetes, biomarkers of diabetes, nutrition and pediatrics for diabetic patients, nursing care plans for diabetic patients. This Conference provides a novel scope to improve the knowledge about the lifestyle of diabetic patients and also about the preventive measures that should be taken by the diabetic patients.

Why to attend?

26th International Conference on Diabetes and Endocrinology will provide a global network of eminent speakers, researchers, scientists, professionals, doctors, related individuals and academies to gain knowledge on the title of Diabetes and also about the recent clinical advancements to fight with diabetes. We are sure that you will find this to be a exciting meeting presenting the clinical research on diabetes.

Welcome Message

It is our immense pleasure to welcome you to attend the 26th International Conference on Diabetes and Endocrinology, to be held on November 22-23,2018 in Paris, France.

The theme of the conference is Clinical Advancements and Modern Approaches in the Field of Diabetes which mainly focuses on signs and symptoms, causes, pathophysiology, etiology, diagnosis nursing care, prevention and management of diabetes mellitus. The theme of the Conference will highlight the need for alliance and associations from a wide range of professional backgrounds.

The Conference will provide a forum for you to energize your knowledge and explore the innovations in clinical diabetes. The conference will endeavor to extend stacks of webbing opportunities, giving time to come across and communicate with the scientists and researchers, friends and colleagues as well as promoters and pioneers.

France is an ideal location allowing for simple access to the surrounding area. Additionally, traditional French Bistro Cuisine is present in the restaurant, offering views of the amazing Paris. 

We hope you will join us and take a little time to enjoy the one and only charm of this region.

Sessions/Tracks

Session on: Diabetes Mellitus

Diabetes may be a common chronic illness that imposes right smart demands on the individual tending system. Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus and Gestational Diabetes Mellitus are the types of diabetes. Type 1 Diabetes Mellitus outcomes from the auto-immune destruction of the insulin producing beta cells in the pancreas.Type 1 diabetes can be depicted from type 2 diabetes by auto-antibody testing and C-peptide test. Type 1 diabetes represents 10% of all diabetic cases. Type 2 Diabetes Mellitus is a a metabolic disorder that is characterized by insulin resistance and relative absence of insulin. Approximately 90% of patients suffer from type 2 diabetes. Sudden raise in the blood glucose levels due to placental hormones, during pregnancy leads Gestational Diabetes Mellitus. In addition to this, Type 3 Diabetes Mellitus is portrayed by the insulin resistance to brain which leads to Alzheimer’s disease.

Related Societies and Associations:

American Association of Diabetes Educators | European Society of Endocrinology | Australian Diabetes Society | Diabetes Association of Nigeria.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference


Session on: Pathophysiology of Diabetes Mellitus

The pathophysiological modification is a change notable from a structural defect. Diabetes mellitus mainly occurs when there is an imbalance between the demand and production of insulin hormone. In all types of diabetes, insulin and improper insulin receptors play a major role. If the glucose remains in blood for a long time then the kidneys reach to threshold stage and the glucose is excreted through urine. Then there is a need for re-absorption of water by the kidneys which leads to frequent urination. By this kidney failure occurs.

Autoimmune destruction

Hyperglycemia

Insulin resistance

Related Societies and Associations:

American Association of Diabetes Educators | Canadian Diabetes Association | Italian Association for the Defense of the Interests of Diabetics.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference

22nd Prevention of Diabetes and Complications Conferences October 12-13, 2017 London, UK | 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy | 3rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland | 3rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK | 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands | 13th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland | 2nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland | 3rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland.


Session on: Diabetic Life

Some people feel embarrassed to let the world know about their diabetic condition. But letting people know about your condition can mean that you can receive more support and understanding from others. For diabetic patients diabetes is the primary factor in every decision. Though it is a deadly disease, early diagnosis and proper medication reduces the risk of deaths. Conference on Clinical Diabetes helps us to get out of the questions about diabetes in our day to day life.

Diabetes checks

Illness

Life expectancy

Smoking

Body Piercing

Related Societies and Associations: 

Diabetes Australia | Diabetes Canada | Association of Diabetes Educators | American Diabetes Association.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference

17th Global Diabetes Conferences & Nursing Care Conferences March 8-9, 2018 Paris, France | 3rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland | 29th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany | 3rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK | 4th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland | 13th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland | 2nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland | 3rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland.


Session on: Gestational Diabetes Mellitus

Gestational Diabetes Mellitus(GDM) happens only during pregnancy. GDM usually happens in second half of the pregnancy. Doctors check for GDM between weeks 24 - 28. During pregnancy placenta makes a hormone called Human Placental Lactogen(HPL), which can buildup extra glucose in blood. This extra glucose in mother’s blood stream crosses the placenta and triggers the baby’s pancreas to make extra insulin, and with this the baby grows too large which leads to macrosomia(extra weight). GDM women have high infant birth - weight when compared to non-GDM. According to American Pregnancy Association 2-5% of pregnant women develop Gestational Diabetes Mellitus(GDM) every year.

Related Societies and Associations: 

American Diabetes Association | Baker Heart and Diabetes Institute | Diabetic Society of Singapore | French Diabetics Association.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference

27th European Diabetes Conferences June 11-12, 2018 Rome, Italy | 3rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland | Public Health and Nutrition Conference February 26-28, 2018 London, UK | 3rd Health Economics and Patient Safety Conference April 12-13, 2018 Amsterdam, Netherlands | 13th Healthcare and Technologies Conference June 14-15, 2018 Dublin, Ireland | 2nd Patient Safety and Healthcare Conference June 21-22, 2018 Dublin, Ireland. 


Session on: Complications of Diabetes Mellitus

High levels of sugars or glucose in blood leads to such a chronic condition called diabetes mellitus. High glucose in blood may cause eye damage, kidney damage and nerve damage. Diabetes increases the risk of various cardiovascular diseases such as coronary artery disease,heart attack, heart stroke and narrowing of arteries which reduces the blood flow through the arteries. High levels of glucose in blood can damage blood vessels and nerves causing loss of sensation in sexual organs, which leads to sexual dysfunction. In addition to this, people with diabetes have more chances to develop infections that may lead to allergies. Diabetes is the main cause for cardiovascular diseases, kidney failure and blindness. Diabetes can also cause foot ulcers and hearing problems, people with diabetes have hearing impairment commonly. Conference about Diabetes can help you to know about the long-term complications.

Related Societies and Associations: 

American Association for Clinical Endocrinology | Central European Diabetes Association | Asian Diabetic Association | International Diabetes Federation.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference

22nd International Congress on Prevention of Diabetes and Complications  October 12-13, 2017 London, UK | 9th Annual Congress on Endocrine Disorders and Therapies  October 30- November 1, 2017 | 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders  November 2-4, 2017 Bangkok, Thailand | 25th Global Diabetes Summit and Medicare Expo December 04-05, 2017 Dubai, UAE | 10th International Conference on Endocrinology  October 30-November 01, 2017 Chicago, Illinois, USA | 17th Global Diabetes Conference and Medicare Expo March 8-9, 2018 Paris, France | 27th European Diabetes Congress  June 11-12, 2018 Rome, Italy | International Conference on Diabetes and its Complications  May 21-22,2018 Osaka, Japan.


Session on: Diabetic Nephropathy 

Diabetic Nephropathy is the chronic loss of functioning of the kidneys occurring in those with diabetes. This is also known as End-Stage Renal Disease(ESRD). Not everyone with diabetes has kidney failure, around 40% of people with diabetes can develop nephropathy. Usual symptom is frequent urination, urine usually doesn’t contain protein albumin, but in some cases your kidneys are not able to filter the protein out the way they should and then the problem is diagnosed as diabetic nephropathy. Other symptoms include tiredness, headaches, nausea, vomiting and itching. Risk factors include poor control of blood glucose, uncontrolled high blood pressure, past or current cigarette use, a family history of diabetic nephropathy. Diabetic Nephropathy has increased risk of death in general.

Related Societies and Associations:

Australian Diabetes Society | Asian Association for the study of Diabetes | International Diabetes Federation | Diabetes Canada.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference

International Conference on Diabetes and its Complications  May 21-22,2018 Osaka, Japan | 25th Global Diabetes Summit and Medicare Expo December 04-05, 2017 Dubai, UAE | 27th European Diabetes Congress  June 11-12, 2018 Rome, Italy | 22nd International Congress on Prevention of Diabetes and Complications  October 12-13, 2017 London, UK | 9th Annual Congress on Endocrine Disorders and Therapies Diabetes October 30- November 1, 2017 | 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders  November 2-4, 2017 Bangkok, Thailand.


Session on: Diabetic Neuropathy

It is a nerve damage usually occurring in those with diabetes. High levels of glucose in your blood may damage nerve fibers throughout the body leading to diabetic neuropathy. Peripheral Neuropathy is the disorder of nerves other than the brain and the spinal cord. This affects the nerves from arms, hands, feet, legs, internal organs, mouth and face. Symptoms include tingling, numbness, unusual sensations, weakness, or burning pain in the affected area. In Autonomic Neuropathy damage occurs to the nerves that manage daily functions such as blood pressure, digestive system, heart rate and bladder emptying. Radiculoplexus Neuropathy most commonly affects the proximal thigh muscles. Mononeuropathy is caused mostly by the injuries, and if there is any long-term pressure on a nerve due to injury can result in mononeuropathy.

Related Societies and Associations: 

Central European Diabetes Association | Italian Association for the Defense of the Interests of Diabetics | American Diabetes Association.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference

22nd Prevention of Diabetes and Complications?Conferences October 12-13, 2017 London, UK | 27th European Diabetes Conferences June 11-12, 2018 Rome, Italy | 3rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland | 3rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK | 3rd Health Economics and Patient Safety Conferences April 12-13, 2018 Amsterdam, Netherlands | 13th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland | 2nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland | 3rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland.


Session on: Diabetic Retinopathy

Long-term poor control of diabetes mellitus, leads to diabetic retinopathy also known as diabetic eye disease in which the damage occurs to retina and is a leading cause of blindness. Retinal arteries become narrow which reduces the retinal blood flow, dysfunction of the neurons of the inner retina are the earliest changes detected in retina and in later stages there may be changes in the function of the outer retina, which may affect the visual function and the barrier which protects the retina from many substances in the blood called blood retinal barrier got affected leading to the leakage of blood constituents into the retinal neuropile. Diagnosis includes Visual Acuity Test, Pupil Dilation, Opthalmoscopy, Fundus Fluorescein Angiography(FFA), Optical Coherence Tomography(OCT). Most of the people with diabetes have Non-Proliferative Diabetic Retinopathy(NPDR), as it is the early stage of diabetic retinopathy and in this the retinal blood vessels swell and leak, that leads to loss of vision. The advanced stage of diabetic retinopathy is the Proliferative Diabetic Retinopathy(PDR), in this new retinal blood vessels grow(neovascularization), these new blood vessels bleed. If they bleed a lot, vision is blocked.

Related Societies and Associations:

American Optometric Association | American Diabetes Association | Diabetes Association of the Republic of China | Diabetes Canada.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference

25th Global Diabetes Summit and Medicare Expo December 04-05, 2017 Dubai, UAE | 27th European Diabetes Congress  June 11-12, 2018 Rome, Italy | Diabetes 20th Asia Pacific Diabetes Conference  July 9-11, 2018 Sydney, Australia | International Conference on Diabetes and its Complications  May 21-22,2018 Osaka, Japan | 22nd International Congress on Prevention of Diabetes and Complications  October 12-13, 2017 London, UK | 9th Annual Congress on Endocrine Disorders and Therapies  October 30- November 1, 2017 | 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders  November 2-4, 2017 Bangkok, Thailand.


Session on: Etiology of Diabetes Mellitus

Most cases(95%) of type 1 diabetes are the result of environmental factors interacting with a genetically susceptible person. The frequency of disease development in children with a mother who has type 1 diabetes is 2-3% and with a father who has type 1 diabetes is 5-6%. Human Leukocyte Antigen(HLA) class II molecules are strongly associated with type 1 diabetes. Monozygotic twins have 60% chance to develop the disease within 10 years after the first twin is diagnosed. Dizygotic twins have only 8% chance which is similar among siblings.

Related Societies and Associations:

Central European Diabetes Association | Italian Association of Diabetics | International Diabetes Federation | Canadian Diabetes Association.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference

17th Global Diabetes Conferences & Nursing Care Conferences March 8-9, 2018 Paris, France | 3rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland | 29th Prevention of Diabetes and Complications Conferences September 27-28, 2018 Berlin, Germany | 3rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK | 4th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland | 13th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland | 2nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland | 3rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland.


Session on: Nutrition and Pediatrics of Diabetes Mellitus

It’s very important for us to get educated about the nutrition of diabetes to manage our own health. Obesity is the evil contributor for diabetes and genetics also play an equal role. Avoiding the sugar completely is not correct. Nutrient rich food containing all the essential components can help you to stay healthy even with the disorder.

Pediatric diabetes is a condition in children with endocrine glands disorder such as variations of physical growth, diabetes and many more. Pediatric type 1 diabetes represents the inability to produce insulin due to autoimmune destruction of beta cells. Children with type 2 diabetes are at higher risk of developing cardiovascular diseases. Approximately 13,000 children are diagnosed with diabetes every year.

Related Societies and Associations:

American Association of Diabetes Educators | European Society of Endocrinology | Australian Diabetes Society | Diabetes Association of Nigeria.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference

20th Asia Pacific Diabetes Conference July 9-11, 2018 Sydney, Australia | International Conference on Diabetes and its Complications  May 21-22,2018 Osaka, Japan | 25th Global Diabetes Summit and Medicare Expo December 04-05, 2017 Dubai, UAE | 27th European Diabetes Congress  June 11-12, 2018 Rome, Italy | 22nd International Congress on Prevention of Diabetes and Complications  October 12-13, 2017 London, UK | 9th Annual Congress on Endocrine Disorders and Therapies Diabetes October 30- November 1, 2017 | 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders  November 2-4, 2017 Bangkok, Thailand.


Session on: Biomarkers for Diabetes Mellitus

Biomarkers also called ‘molecular markers’ or ‘signature molecules’ are the biological molecules found in blood, tissues and other body fluids and are used to check how well the body is responding to a particular disease. These are the “direct markers” or “indirect markers” of the extent of a disease. Hemoglobin A1c(HbA1c) is considered as a biomarker for the presence of Hyperglycemia(Diabetes Mellitus). Usage of biomarkers in the growth of anti-diabetic drugs will depend on understanding of the pathogenesis of diabetes

Related Societies and Associations:

Diabetes Australia | Diabetes Canada | Association of Diabetes Educators | American Diabetes Association.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference

22nd International Congress on Prevention of Diabetes and Complications, October 12-13, 2017 London, UK | 9th Annual Congress on Endocrine Disorders and Therapies  October 30- November 1, 2017 | 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders  November 2-4, 2017 Bangkok, Thailand | 25th Global Diabetes Summit and Medicare Expo December 04-05, 2017 Dubai, UAE | 10th International Conference on Endocrinology  October 30-November 01, 2017 Chicago, Illinois, USA | 17th Global Diabetes Conference and Medicare Expo March 8-9, 2018 Paris, France | 27th European Diabetes Congress  June 11-12, 2018 Rome, Italy | 20th Asia Pacific Diabetes Conference  July 9-11, 2018 Sydney, Australia | International Conference on Diabetes and its Complications  May 21-22,2018 Osaka, Japan.


Session on: Current focuses on Diabetes Mellitus

Reprogramming skin cells to produce Insulin - Skin cells were grown in a culture medium, in a laboratory, to develop into specialized beta cells, which produces insulin. This development could lead to new treatments for patients with diabetes using their own skin cells.

Improving longevity of Islet cell transplants - This study focuses on islet transplant i.e., clusters of insulin producing beta cells that live in islets are taken from a donor pancreas and implanted in the recepient’s liver to make insulin.

Making more use of Gut hormones - This study focuses on the usage of gut hormones such as Incretins which are involved in controlling the rise of blood glucose after eating.

Related Societies and Associations: 

American Association for Clinical Endocrinology | Central European Diabetes Association | Asian Diabetic Association | International Diabetes Federation.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference 

23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders  November 2-4, 2017 Bangkok, Thailand | 25th Global Diabetes Summit and Medicare Expo December 04-05, 2017 Dubai, UAE | 10th International Conference on Endocrinology  October 30-November 01, 2017 Chicago, Illinois, USA | 17th Global Diabetes Conference and Medicare Expo March 8-9, 2018 Paris, France | 27th European Diabetes Congress  June 11-12, 2018 Rome, Italy | 20th Asia Pacific Diabetes Conference  July 9-11, 2018 Sydney, Australia | International Conference on Diabetes and its Complications  May 21-22,2018 Osaka, Japan | 22nd International Congress on Prevention of Diabetes and Complications  October 12-13, 2017 London, UK |  9th Annual Congress on Endocrine Disorders and Therapies  October 30- November 1, 2017.


Session on: Case Studies on Diabetes Mellitus

Case study techniques encloses the case history of a single participant or a group of individuals i.e., idiographic approach. Olanzapine is the drug used to treat bipolar disorder and doctors proved that the patients taking olanzapine had a significantly increased risk of developing diabetes. Pioglitazone is the drug used for patients with type 2 diabetes and they have an increased risk of developing bladder cancer. Relative risk for fatal coronary heart disease associated with diabetes is 50% higher in women than in men.

Related Societies and Associations:

American Diabetes Association | Central European Diabetes Association | Asian Association for the study of Diabetes | International Diabetes Federation.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference

20th Asia Pacific Diabetes Conference  July 9-11, 2018 Sydney, Australia | International Conference on Diabetes and its Complications  May 21-22,2018 Osaka, Japan |  25th Global Diabetes Summit and Medicare Expo December 04-05, 2017 Dubai, UAE | 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders  November 2-4, 2017 Bangkok, Thailand | 27th European Diabetes Congress  June 11-12, 2018 Rome, Italy | 22nd International Congress on Prevention of Diabetes and Complications  October 12-13, 2017 London, UK | 9th Annual Congress on Endocrine Disorders and Therapies  October 30- November 1, 2017.


Session on: Nursing Care for Diabetes Mellitus

Nursing management of diabetes includes effectual treatment to normalize blood glucose levels and reduce complications using insulin replacement, balanced diet and regular exercise. Nursing management includes teaching patient’s needs, abilities and developmental stage.

Nursing care plans includes risk for unstable blood glucose, risk for injury, fatigue, risk for infection, imbalanced nutrition, deficient knowledge of diabetes management, stress, insulin deficiency or excess, assessment(Medicines, Allergies, Symptoms, Family history), nursing diagnosis(Anxiety and Fear, Fluid volume deficit).

Related Societies and Associations: 

American Diabetes Association | Canadian Diabetes Association | International Diabetes Federation | Diabetes Association of Nigeria.

Recommended: Diabetes Conference | Clinical Diabetes Conference | Diabetes and Endocrinology Conference | Diabetes Conference 2018 | Medical Conference

17th Global Diabetes Conferences & Nursing Care Conferences March 8-9, 2018 Paris, France | 3rd Metabolic Syndrome Conferences June 18-19, 2018 Dublin, Ireland | 29th Prevention of Diabetes and Complications?Conferences September 27-28, 2018 Berlin, Germany | 3rd Public Health and Nutrition Conferences February 26-28, 2018 London, UK | 4th Health Economics, Health Policy and Health care Management September 13-14, 2018 Zurich, Switzerland | 13th Healthcare & Technologies Conferences June 14-15, 2018 Dublin, Ireland | 2nd Patient Safety and Quality Healthcare June 21-22, 2018 Dublin, Ireland | 3rd Environmental Health Conferences October 15-16, 2018 Warsaw, Poland.



Market Analysis

Presently diabetes is the fastest growing disease in the world. In US most of the people are affected with type 1 diabetes(approximately 5-10%). There are nearly 1.5-5.0 million deaths per year from 2012-2015.

World diabetes day is celebrated on November 14 and was introduced by the International Diabetes Federation(IDF) and the World Health Organization(WHO).



By 2030 it is estimated that type 2 diabetes is set to increase to 438 million from 285 million people recorded in 2010. India has around 50 million people suffering from type 2 diabetes and India is the diabetes capital of the world. According to IDF, 1 in 11 adults in the world are suffering from diabetes and diabetes is the number one cause for kidney failure. Diabetes is increasing because of sedentary lifestyle. WHO estimated that 80% of diabetic deaths occur in low-income and middle-income countries.


NEW PROJECTS SIGNED BY WORLD DIABETES FOUNDATION:

Community-based detection and surveillance of gestational diabetes

Strengthening Management, Diagnosis and surveillance

Nurses led Rural Diabetes Prevention and Management

Improved prevention and care of diabetes and hypertension

Diabetes education and awareness program

Managing Diabetes for older people

Diabetes foot care/Podiatry Nigeria

Preventing diabetes related adverse consequences of pregnancies


INTERNATIONAL DIABETES ASSOCIATIONS:

American Diabetes Association

World Diabetes Foundation

International Diabetes Federation

Latino Diabetes Association

Juvenile Diabetes Association

Missouri Diabetes Association

Canadian Diabetes Association


GLOBAL STATISTICS:

Over the past few decades number of cases of diabetes have been increasing steadily.

Global diabetes drug market was valued at 49.26 billion dollars in 2016 and is projected to reach global revenue of 66.29 billion dollars in 2021. Most used drug in the market in 2016 was human insulin.

Global diabetes market valued $125 billion in 2016 and is expected to reach $155 billion by 2021.

Global market for incretin-based therapeutics was valued $12.7 billion in 2014 and is expected to reach $22.8 billion by 2019.

Global market for obesity treatments should reach over $7.8 billion by 2021 from $4.3 billion in 2016.

Global market for Continuous Glucose Monitoring(CGM) products valued $320.9 million n 2014 and is expected to reach $783.9 million by 2019.



The statistics shows global spending on diabetes in both developed markets and pharmerging markets from 2013-2018. In 2013, the developed diabetes market expended 35 billion U.S. dollars on diabetes. In 2018, it is estimated to be 66 billion U.S. dollars.International Diabetes Federation(IDF) estimated the total number of adult diabetics all over the world at around 425 million. In 2045 it is estimated as 629 million.



This statistics displays the top 10 pharmaceutical companies by global anti-diabetic revenue in 2016 and 2022, in million U.S. dollars. In 2016, Merck and Co generated about 6.14 billion U.S. dollars in anti-diabetic revenue and is expected to generate nearly 6.5 billion U.S. dollars by 2022. Anti-diabetic medication is commonly ingested orally, except insulin.



This shows us the countries with the highest number of diabetics in 2017. As of 2017, China was the country with the highest number of diabetics worldwide.


Organizing Committee
OCM Member
Dr. Prem Sahasranam MD
CEO and Medical Director
Central Valley Endocrinology, APC
Burlingame, USA
OCM Member
Dr. Alireza Heidari
Director of the BioSpectroscopy Core Research Laboratory
California South University
California, USA
OCM Member
Dr. Haleama Al Sabbah
Chair of Health Sciences Department at Zayed University
Zayed University
Dubai, United Arab Emirates
OCM Member
Vivek Kamath
Founder and CEO Heal The World.
Heal the World
Cuttack, India
OCM Member
Peter Kokkinos
Director, Human Performance Research Unit and Cardiometabolic Research Unit, Veterans Affairs Medical Center and Georgetown University School of Medicine
Veterans Affairs Medical Center and Georgetown University School of Medicine
cambridge , USA
OCM Member
Amendezo Etienne
MD, MMed (Int.Med), Internal Medicicne
King Faisal Hospital Kigali · Internal Medicine
Butare, Rwanda
OCM Member
Dr. P.H.L.M. Geelhoed-Duijvestijn
Endocrinologist, Haaglanden Medical Centre
Haaglanden Medical Centre The Hague, The Netherlands
Rotterdam, Netherlands
Renowned Speakers

To Collaborate Scientific Professionals around the World

Conference Date November 22-23, 2018
Speaker Oppurtunity
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Sponsorship Opportunities Click here for Sponsorship Opportunities
Venue
&
Hospitality

To Be Updated

Join The Discussion

Contact Desk

Drop us an email for Program enquiry

Christie Amelia

diabetes@diabeticconferences.com

+44 20 3769 1755

Sponsors/Exhibiting/Advertising

Anna L Cunningham

sponsoraac@alliedacademies.com

+44 20 3769 1755

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by

Allied Academies Global Conference Directory

Mail us at

Drop us an email for Program enquiry
diabetes@diabeticconferences.com
Sponsors/Exhibiting/Advertising
sponsoraac@alliedacademies.com
General Queries
diabetes@alliedconferences.org
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund arrangements apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overheads, we had to keep Refund Policy is as following slabs-

  • Before 60 days of the conference: Eligible for Full Refund less $100 service Fee
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

Highlights from last year's Convention

Copyright © 2018-2019 Allied Academies, All Rights Reserved.